Physician profile
Mark G Belza
NPI 1740284777
$9,451.83
in general payments reported to CMS, 2019-2025
20 companies · $2,086 in 2025
The $2,086 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,818 · 2020: $2,407 · 2021: $53.50 · 2022: $379 · 2023: $251 · 2024: $457 · 2025: $2,086.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000 · Food and Beverage: $794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
| Food and Beverage | $794.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $5,980.54 | 2019-2025 | |
| Aesculap Implant Systems, LLC | $1,372.25 | 2019 | |
| Globus Medical, INC. | $554.15 | 2019-2020 | |
| Boston Scientific Corporation | $362.78 | 2019-2024 | |
| Abbott Laboratories | $248.91 | 2019-2022 | |
| Intrinsic Therapeutics | $210.00 | 2022 | |
| Cerapedics INC. | $132.07 | 2023-2024 | I-Factor Peptide Enhanced Bone Graft |
| Stryker Corporation | $125.27 | 2020-2024 | N/A, Avs Navigator |
| Si-Bone, INC. | $101.50 | 2024 | |
| Nuvasive, INC. | $79.25 | 2019 | |
| Medtronic, INC. | $48.83 | 2021-2022 | |
| Abbvie INC. | $43.64 | 2024 | |
| Nevro Corp. | $38.62 | 2019-2024 | Senza |
| Medtronic USA, INC. | $30.32 | 2019 | |
| Lemaitre Vascular, INC. | $27.98 | 2019-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insightec,INC | $26.63 | 2019 | |
| Vertos Medical, INC. | $19.80 | 2024 | Mild Device Kit |
| Assertio Therapeutics, INC. | $19.59 | 2019 | |
| Integra Lifesciences Corporation | $17.45 | 2021 | |
| Seaspine Orthopedics Corporation | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Belza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.